Jan Stahlberg - Net Worth and Insider Trading
Jan Stahlberg Net Worth
The estimated net worth of Jan Stahlberg is at least $22 Million dollars as of 2024-11-08. Jan Stahlberg is the 10% Owner of DiaMedica Therapeutics Inc and owns about 5,221,608 shares of DiaMedica Therapeutics Inc (DMAC) stock worth over $22 Million. Details can be seen in Jan Stahlberg's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jan Stahlberg has not made any transactions after 2024-06-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jan Stahlberg
Jan Stahlberg Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jan Stahlberg owns 1 companies in total, including DiaMedica Therapeutics Inc (DMAC) .
Click here to see the complete history of Jan Stahlberg’s form 4 insider trades.
Insider Ownership Summary of Jan Stahlberg
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DMAC | DiaMedica Therapeutics Inc | 2024-06-28 | 10 percent owner |
Jan Stahlberg Latest Holdings Summary
Jan Stahlberg currently owns a total of 1 stock. Jan Stahlberg owns 5,221,608 shares of DiaMedica Therapeutics Inc (DMAC) as of June 28, 2024, with a value of $22 Million.
Latest Holdings of Jan Stahlberg
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DMAC | DiaMedica Therapeutics Inc | 2024-06-28 | 5,221,608 | 4.18 | 21,800,213 |
Holding Weightings of Jan Stahlberg
Jan Stahlberg Form 4 Trading Tracker
According to the SEC Form 4 filings, Jan Stahlberg has made a total of 1 transactions in DiaMedica Therapeutics Inc (DMAC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in DiaMedica Therapeutics Inc is the acquisition of 1,200,000 shares on June 28, 2024, which cost Jan Stahlberg around $3 Million.
Insider Trading History of Jan Stahlberg
- 1
Jan Stahlberg Trading Performance
GuruFocus tracks the stock performance after each of Jan Stahlberg's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jan Stahlberg is 41.69%. GuruFocus also compares Jan Stahlberg's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jan Stahlberg within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jan Stahlberg's insider trading performs compared to the benchmark.
Performance of Jan Stahlberg
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 23.39 |  | | | | |
| Relative Return to S&P 500(%) | 23.42 | | | | | |
Jan Stahlberg Ownership Network
Ownership Network List of Jan Stahlberg
Ownership Network Relation of Jan Stahlberg
Jan Stahlberg Owned Company Details
What does DiaMedica Therapeutics Inc do?
Who are the key executives at DiaMedica Therapeutics Inc?
Jan Stahlberg is the 10 percent owner of DiaMedica Therapeutics Inc. Other key executives at DiaMedica Therapeutics Inc include 10 percent owner Koch Thomas Von , CFO and Secretary Scott Kellen , and director & President and CEO Dietrich John Pauls .
DiaMedica Therapeutics Inc (DMAC) Insider Trades Summary
Over the past 18 months, Jan Stahlberg made 1 insider transaction in DiaMedica Therapeutics Inc (DMAC) with a net purchase of 1,200,000. Other recent insider transactions involving DiaMedica Therapeutics Inc (DMAC) include a net purchase of 2,670,588 shares made by Koch Thomas Von , a net purchase of 58,364 shares made by David J. Wambeke , and a net purchase of 65,000 shares made by Randall Michael Giuffre .
In summary, during the past 3 months, insiders sold 0 shares of DiaMedica Therapeutics Inc (DMAC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of DiaMedica Therapeutics Inc (DMAC) were sold and 4,067,889 shares were bought by its insiders, resulting in a net purchase of 4,067,889 shares.
DiaMedica Therapeutics Inc (DMAC)'s detailed insider trading history can be found in Insider Trading Tracker table.
DiaMedica Therapeutics Inc Insider Transactions
Jan Stahlberg Mailing Address
Above is the net worth, insider trading, and ownership report for Jan Stahlberg. You might contact Jan Stahlberg via mailing address: C/o Trill Invest Ab, Sveavagen 17 Fl 18, Stockholm V7 Se 111 57.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
